Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
The authorisation is a global first for the age group for the vaccine, which is manufactured and marketed in India by the Serum Institute of India under the brand name Covovax.
Novavax last month said its vaccine was 80 per cent effective against COVID-19 in a late-stage trial testing the shot in 2,247 teens aged 12 to 17 years. Read full story
The company said on Tuesday its vaccine produced an immune response in the same age group in a mid- to late-stage study involving 460 Indian adolescents.
Covovax is the fourth COVID-19 vaccine to be authorised for adolescents aged 12 years and older in India after Corbevax, ZyCoV-D and Covaxin.
India, which had so far been vaccinating children aged 15 and above, started administering doses of Corbevax last week to children aged 12 to 14.
The country's drug regulator in December authorised Novavax's COVID-19 vaccine for people aged 18 years and above.
The Republican-controlled US Senate passed President Donald Trump's tax and spending bill on Tuesday, signing off on a massive package that would enshrine many of his top domestic priorities into law while adding $3.3 trillion to the national debt.
More than a thousand schools were closed in France on Tuesday and the top floor of the Eiffel Tower was shut to tourists as a severe heatwave continued to grip Europe, triggering health alerts across the region.
Thailand's Constitutional Court on Tuesday suspended Prime Minister Paetongtarn Shinawatra from duty pending a case seeking her dismissal, in a major setback for a government under fire on multiple fronts and fighting for its survival.
President Donald Trump has signed an executive order terminating a US sanctions programme on Syria, allowing an end to the country's isolation from the international financial system and building on Washington's pledge to help it rebuild after a devastating civil war.
Former criminology graduate student Bryan Kohberger has agreed to plead guilty to killing four Idaho college students in 2022, a move that would spare him the death penalty under a deal with prosecutors, according to the family of one of the victims.